What is Mysore Ramprasad email address?

Mysore Ramprasad's primary email address is *************@ambrx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Mysore Ramprasad work for?

Mysore Ramprasad is a Group Leader Formulation and Product Development at Ambrx.

Where Mysore Ramprasad graduated from?

Mysore Ramprasad holds a degree in Postdoctoral Fellowship: Novel Lipoprotein Receptor Purification and Characterization. University of Alabama at Birmingham Ph.D. Molecular Biophysics Structure-Function biophysical characterization of Gelonin: a Ribosomal Inactivating Protein Toxin Indian Institute of Science, Bangalore from University of California San Diego.

How can I directly contact Mysore Ramprasad?

To contact Mysore Ramprasad directly, you can use the email address *************@ambrx.com. Complete contact information is available upon registration with Muraena.

Is Mysore Ramprasad an immigrant?

Yes, Mysore Ramprasad is an immigrant and currently based in United States

Who is Mysore Ramprasad?

Mysore Ramprasad is an accomplished executive with over 27 years of experience in the biopharmaceutical industry, specializing in analytical and formulation development. Currently serving as the Executive Director at Ambrx, he leads critical late-stage development projects for antibody-drug conjugates (ADCs), focusing on regulatory submissions and formulation robustness. His extensive background includes roles in both corporate and contract development manufacturing organizations, where he has successfully overseen numerous IND-enabling studies and innovative drug delivery systems. Known for his strategic thinking and leadership, he has mentored teams to excel in high-stakes environments, ensuring compliance with global health authority standards. His academic credentials include a Ph.D. in Molecular Biophysics, underscoring his deep technical expertise in biopharmaceuticals. A patent inventor, he actively contributes to advancements in drug formulation technologies, with a keen interest in improving patient outcomes through innovative therapies.